GLUE
Monte Rosa Therapeutics, Inc. · Healthcare · Biotechnology
Momentum-Eingaben (vergleichbare Manager):
Halterbreite +8.3% ·
Aktienfluss +6.6% ·
neue Nettopositionen +7.7%
— Formel
Breite Akkumulation — steigende Anteile bei mehr Haltern
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q2 2025
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 78 | -3 | 40.75M | $985.52M | +5 | −8 |
| Q1 2026 | 84 | +11 | 37.29M | $613.27M | +14 | −3 |
| Q4 2025 | 73 | -1 | 26.21M | $411.01M | +1 | −2 |
| Q3 2025 | 18 | +2 | 20.02M | $148.32M | +2 | — |
| Q2 2025 | 13 | +1 | 20.51M | $92.50M | +1 | — |
| Q1 2025 | 9 | -3 | 9.96M | $46.20M | +1 | −4 |
| Q4 2024 | 12 | +2 | 11.82M | $82.01M | +2 | — |
| Q3 2024 | 9 | +2 | 9.48M | $50.23M | +2 | — |
| Q2 2024 | 7 | — | 8.29M | $30.99M | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 6.33M | -4.8% | $28.53M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 6.33M | -4.8% | $28.53M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 3 | BlackRock ✦ (passiv) | 3.85M | — | $17.35M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (passiv) | 3.85M | — | $17.35M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (passiv) | 3.85M | — | $17.35M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (passiv) | 3.85M | — | $17.35M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (passiv) | 3.85M | — | $17.35M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (passiv) | 3.85M | — | $17.35M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (passiv) | 3.85M | — | $17.35M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (passiv) | 3.85M | — | $17.35M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | The Vanguard Group ✦ (passiv) | 3.14M | — | $14.16M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | The Vanguard Group ✦ (passiv) | 3.14M | — | $14.16M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | The Vanguard Group ✦ (passiv) | 3.14M | — | $14.16M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Fidelity (FMR) ✦ | 2.29M | — | $10.32M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Fidelity (FMR) ✦ | 2.29M | — | $10.32M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Fidelity (FMR) ✦ | 2.29M | — | $10.32M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 1.28M | +459.4% | $5.79M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 1.28M | +459.4% | $5.79M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 1.28M | +459.4% | $5.79M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 1.28M | +459.4% | $5.79M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 1.28M | +459.4% | $5.79M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 22 | Geode Capital Management ✦ (passiv) | 1.12M | +12.0% | $5.07M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 23 | Geode Capital Management ✦ (passiv) | 1.12M | +12.0% | $5.07M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 24 | State Street Global Advisors ✦ (passiv) | 831.82K | +3.8% | $3.75M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 25 | Renaissance Technologies ✦ | 615.10K | +274.8% | $2.77M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 26 | Marshall Wace ✦ | 446.08K | +20.0% | $2.01M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 27 | Marshall Wace ✦ | 446.08K | +20.0% | $2.01M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 28 | Two Sigma Investments ✦ | 239.94K | +7.5% | $1.08M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 29 | Wellington Management ✦ | 224.82K | +19.8% | $1.01M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 30 | Wellington Management ✦ | 224.82K | +19.8% | $1.01M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 31 | Wellington Management ✦ | 224.82K | +19.8% | $1.01M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 32 | Citadel Advisors ✦ | 77.92K | Neu | $351,411 | 0.0% | New | 1 | SEC ↗ |
| 33 | Citadel Advisors ✦ | 77.92K | Neu | $351,411 | 0.0% | New | 1 | SEC ↗ |
| 34 | Millennium Management ✦ | 64.63K | -80.4% | $291,486 | 0.0% | ▼ Trim | 5 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Citadel Advisors | $351,411 | 0.0% |
| Citadel Advisors | $351,411 | 0.0% |
Ausgestiegen
| Keine erfassten Ausstiege in diesem Quartal. |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 188 Inhaber, 86.88M Anteile, $1.31B gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.